Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) ...

After hitting a record high, the U.S. rate of obesity is falling, as the number of people taking GLP-1 medications rises stockvisual/Getty The rate of obese Americans has declined three years after ...

WASHINGTON -- New research is boosting hopes that weight-loss surgery can put some patients' diabetes into remission for years and perhaps in some cases, for good. Doctors on March 31 gave longer ...

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...

Obstructive sleep apnea (OSA) is prevalent in obese, pregnant Asian women with gestational diabetes, even when their diabetes is controlled by diet, a new study from Thailand finds. Study results, ...

A recent JAMA Network Open study investigated the factors associated with semaglutide initiation among obese adults without diabetes and with commercial insurance. The demand for novel GLP-1 receptor ...